Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frederick Pierce II currently holds 34,844 shares of Decoy Therapeutics Inc. (DCOY), valued at approximately $0. This represents their equity stake as Chief Executive Officer.
Based on SEC Form 4 filings, Frederick Pierce II has been a net neutral trader of DCOY stock. They have purchased $0 and sold $0 worth of shares.
Frederick Pierce II's most recent insider trade was on Aug 31, 2026, when they sold 33,455 shares at $0.00 per share.
Frederick Pierce II serves as Chief Executive Officer at Decoy Therapeutics Inc. (DCOY). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Frederick Pierce II holds the position of Chief Executive Officer at Decoy Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Frederick Pierce II has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Frederick Pierce II was on Aug 31, 2026, when they purchased $0 worth of DCOY shares. This transaction involved 33,455 shares at N/A per share.
Frederick Pierce II currently owns 34,844 shares of Decoy Therapeutics Inc. (DCOY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frederick Pierce II's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frederick Pierce II has 1 Form 4 filings on record as an insider at Decoy Therapeutics Inc..
Set alerts for Frederick Pierce II and 40,000+ other insiders.